For example, although much focus has been placed on targeting oncogenes in amplified/gained regions, their subclonal nature in TP53-mutant polyploid tumours suggests that such strategies will eventually fail owing to a reservoir of resistant non-altered cells within the tumour mass. Here, TP53 is linked to neoplasm.